| spoke-okn ↔ nde | DOID | 20 | Infectious/immune-mediated disease datasets (NDE) for a disease, with that disease's spoke-okn associations, joined on DOID.
For an NDE infectious-disease dataset (DOID), what candidate compounds does spoke-okn associate with that disease, surfacing repurposing leads? |
| gene-expression-atlas-okn → ubergraph → spoke-okn | DOID↔MONDO | 54 | spoke-okn gene/compound/prevalence associations for diseases GXA profiles by differential expression, bridged EFO->MONDO->DOID.
Do the genes spoke-okn associates with a disease (DOID) overlap GXA's differentially-expressed genes for the same disease, bridged EFO->MONDO->DOID? |
| spoke-okn → ubergraph → oard-kg | DOID↔MONDO | 40 | EHR-derived disease-phenotype associations (OARD, MONDO) for a spoke-okn disease (DOID), bridged through ubergraph.
For an OARD-profiled disease (MONDO), pull spoke-okn's gene and compound associations by bridging MONDO->DOID through ubergraph. |
| spoke-okn → ubergraph → prokn | DOID↔MONDO | 115 | spoke-okn disease associations (genes/compounds/prevalence/mortality) for diseases ProKN also describes, joined on DOID.
For a ProKN disease with marker-gene proteins, does spoke-okn associate the same genes with the matching DOID disease, bridged MONDO->DOID? |
| spoke-okn → ubergraph → rdkg | DOID↔MONDO | 149 | Rare-disease gene/drug associations (rdkg, MONDO) for a spoke-okn disease (DOID), bridged through ubergraph DOID->MONDO.
Do spoke-okn's associated compounds for a disease (DOID) match RDKG's DrugBank treating/contraindicated drugs for the same MONDO disease? |
| spoke-okn → ubergraph → digcfdekg | DOID↔MONDO (+ EFO/Orphanet→MONDO) | 50 | spoke-okn disease associations (genes/compounds/prevalence) for diseases CFDE REVEAL has factor inferences on, bridged DOID->MONDO through ubergraph.
For a CFDE REVEAL disease trait (MONDO), which spoke-okn genes for the matching DOID disease overlap the inferred gene-trait factors, bridged MONDO->DOID? |
| digcfdekg ↔ gene-expression-atlas-okn | EFO / Orphanet / MONDO (direct, multi-vocabulary) | 33 | Differential-expression studies (GXA) for diseases CFDE REVEAL has gene-trait factor inferences on, matched on EFO/Orphanet/MONDO.
Do the genes GXA finds differentially expressed for a disease overlap the genes CFDE REVEAL ties to the same trait (EFO/Orphanet/MONDO), corroborating inferred factors with expression evidence? |
| gene-expression-atlas-okn → ubergraph → nde | EFO↔MONDO | 325 | NIAID infectious/immune-disease datasets (nde) for diseases GXA profiles by differential expression, via the EFO->MONDO bridge.
How many of NDE's NIAID disease datasets (MONDO) have a corresponding GXA differential-expression study, bridged EFO->MONDO? |
| gene-expression-atlas-okn → ubergraph → oard-kg | EFO↔MONDO | 159 | EHR-derived disease-phenotype associations (OARD) for diseases GXA profiles by differential expression, via the EFO->MONDO bridge.
Which OARD diseases with the strongest EHR phenotype signals (MONDO) also have GXA transcriptomic data, via the EFO->MONDO bridge? |
| gene-expression-atlas-okn → ubergraph → rdkg | EFO↔MONDO | 414 | Rare-disease gene/drug associations (rdkg) for diseases GXA has differential-expression studies on, via the EFO->MONDO bridge.
Which RDKG rare diseases with known drug treatments (MONDO) also have a GXA differential-expression study, via the EFO->MONDO bridge? |
| gene-expression-atlas-okn ↔ oard-kg | HP | 13 | EHR-derived phenotype co-occurrences (OARD) for the phenotypes GXA studies, joined on HP.
For a phenotype GXA profiles by expression (HP), which diseases does OARD show it co-occurring with in EHR data? |
| gene-expression-atlas-okn ↔ prokn | HP | 12 | ProKN protein/marker-gene evidence for the phenotypes GXA studies, joined on HP.
Do ProKN's marker genes for a phenotype (HP) coincide with the genes GXA finds differentially expressed for the same phenotype? |
| oard-kg ↔ prokn | HP | 4,941 | Phenotypes clinically associated with rare diseases (OARD) that also have protein/marker-gene evidence (ProKN).
For hepatomegaly (HP), list the marker-gene proteins ProKN attaches alongside the diseases OARD shows it co-occurring with in EHR data. |
| biomarkerkg ↔ nde | MONDO | 601 | Infectious/immune-mediated disease datasets (NDE) for a disease biomarkerkg also tracks, joined directly on MONDO.
Which of the 601 shared MONDO diseases have both an NIAID dataset in NDE and multiple curated biomarkers in BiomarkerKG, prioritizing data-rich infectious diseases? |
| biomarkerkg ↔ oard-kg | MONDO | 290 | EHR-derived disease-phenotype associations (OARD) for a biomarkerkg disease, joined directly on MONDO.
How many of BiomarkerKG's MONDO diseases also carry OARD EHR phenotype associations, and which biomarkers map to the most clinically-documented diseases? |
| biomarkerkg ↔ prokn | MONDO | 263 | Literature biomarkers for a disease (BiomarkerKG) cross-referenced to protein/marker-gene evidence (ProKN).
For colorectal cancer (MONDO), do BiomarkerKG's literature biomarker proteins coincide with ProKN's marker genes for the same MONDO disease, flagging markers that lack molecular evidence? |
| biomarkerkg ↔ rdkg | MONDO | 754 | Rare-disease gene/drug associations (rdkg) for a biomarkerkg disease, joined directly on MONDO.
Do BiomarkerKG's biomarker genes for a disease (MONDO) match the disease genes RDKG records for the same MONDO disease, cross-validating markers against rare-disease gene panels? |
| nde ↔ oard-kg | MONDO | 889 | NIAID datasets for a disease (NDE) plus its EHR phenotype signature (OARD).
Which MONDO diseases with an NIAID dataset in NDE carry the richest OARD EHR phenotype profiles, ranked by number of associated phenotypes? |
| nestkg ↔ biomarkerkg | MONDO | 13 | For a cancer type whose mutational signal NeST attributes to specific protein systems, which biomarkers does BiomarkerKG list as diagnostic, prognostic or risk markers of that same cancer — and do those biomarkers fall inside the implicated systems?
How many of the 14 NeST cancer types have at least one biomarker in BiomarkerKG? |
| oard-kg ↔ prokn | MONDO | 470 | Diseases with both EHR phenotype associations (OARD) and marker-gene/protein evidence (ProKN).
How many of OARD's MONDO diseases carry ProKN protein evidence, and which of them accumulate the most marker genes? |
| rdkg ↔ oard-kg | MONDO | 2,014 | Rare-disease EHR phenotype profile (OARD) combined with contraindicated/treating drugs (RDKG, DrugBank).
For a DrugBank drug in RDKG, which of the rare diseases it treats also present an EHR phenotype signature in OARD (MONDO)? |
| biomarkerkg → ubergraph → digcfdekg | MONDO (+ EFO/Orphanet→MONDO bridged) | 193 | Biomarker-disease associations (biomarkerkg, MONDO) for diseases CFDE REVEAL has gene-trait factor inferences on, joined on MONDO (CFDE's EFO/Orphanet traits bridged to MONDO through ubergraph).
Do BiomarkerKG's biomarker genes for a disease (MONDO) appear among the genes CFDE REVEAL ties to the same trait, cross-checking markers against inferred factors? |
| digcfdekg → ubergraph → oard-kg | MONDO (+ EFO/Orphanet→MONDO bridged) | 402 | Rare-disease EHR phenotype profile (OARD) combined with the gene-trait factor inferences CFDE REVEAL records for the same disease.
How many CFDE REVEAL disease traits (MONDO) have a matching OARD EHR phenotype profile that could support their inferred gene-trait factors? |
| digcfdekg → ubergraph → rdkg | MONDO (+ EFO/Orphanet→MONDO bridged) | 1,045 | For a rare disease (rdkg, MONDO) with its gene/drug associations, what disease-mechanism factors and gene-trait probabilities does CFDE REVEAL infer?
Do the genes CFDE REVEAL links to a disease trait (MONDO) match RDKG's curated disease genes, validating inferred gene-trait factors against known rare-disease genes? |
| spoke-okn → ubergraph → biomarkerkg | MONDO↔DOID | 107 | Biomarkers for a disease (BiomarkerKB, MONDO) alongside that disease's spoke-okn gene/compound associations (DOID), bridged DOID<->MONDO through ubergraph.
Do BiomarkerKG's biomarker genes for a disease overlap the genes spoke-okn associates with the same disease, reconciling the two gene sets across the DOID<->MONDO bridge? |
| oard-kg → ubergraph → prokn | MONDO↔OMIM | 11 | Cross-reference OARD drug/outcome disease associations (oard-kg, MONDO) with ProKN's OMIM-annotated disease evidence by bridging MONDO to OMIM through ubergraph's cross-references.
For a Mendelian disease ProKN annotates by OMIM, what EHR drug-outcome associations does OARD record, bridging OMIM->MONDO through ubergraph? |
| oard-kg → ubergraph → prokn | MONDO↔Orphanet | 316 | Cross-reference OARD disease associations (oard-kg, MONDO) with ProKN's Orphanet-annotated rare-disease protein evidence by bridging MONDO to Orphanet through ubergraph.
How many of ProKN's Orphanet-annotated rare diseases with protein evidence also surface in OARD's EHR association data, via the MONDO<->Orphanet bridge? |
| biobricks-mesh ↔ spoke-okn | MeSH_descriptor_id | 165 | Map spoke-okn's social-determinants and disease nodes to MeSH (e.g. Social Vulnerability = MeSH D000091482) to pull MeSH definitions / tree placement from biobricks-mesh, or to connect spoke-okn disease nodes to MeSH-tagged concepts - reaching the SDoH layer that the MONDO route (M1) misses.
Starting from a MeSH tree branch (e.g. the Social Determinants of Health descriptor set), enumerate which spoke-okn SDoH and disease nodes fall under it and count the diseases carrying each descriptor. |
| biobricks-ice ↔ biohealth | UMLS | 46 | For the biological target of an ICE tox assay (biobricks-ice, a UMLS concept), what clinical / SDoH associations does biohealth attach to that same concept?
How many of ICE's mechanistic-target UMLS concepts does biohealth's literature graph also describe, joined on the UMLS CUI? |
| biohealth → ubergraph → gene-expression-atlas-okn | UMLS↔HP | 13 | For a phenotype biohealth tracks (UMLS CUI), is there a GXA differential-expression study on it (HP), bridged through ubergraph UMLS->HP?
Which of GXA's HP-typed differential-expression studies correspond to phenotypes biohealth tracks with SDoH context, via the UMLS->HP bridge? |
| biohealth → ubergraph → oard-kg | UMLS↔HP | 4,549 | For a phenotype biohealth tracks (UMLS CUI), what EHR-derived disease co-occurrences does OARD record (HP), bridged through ubergraph UMLS->HP?
Which HP phenotypes with the most OARD EHR disease co-occurrences also carry biohealth SDoH context, via the UMLS->HP bridge? |
| biohealth → ubergraph → prokn | UMLS↔HP | 4,340 | For a phenotype biohealth tracks (UMLS CUI), what protein / marker-gene evidence does prokn attach (HP), bridged through ubergraph UMLS->HP?
How many of ProKN's HP phenotypes with marker-gene evidence map to a biohealth UMLS concept, and which of those carry SDoH context? |
| biohealth → ubergraph → biomarkerkg | UMLS↔MONDO | 835 | For a disease biohealth describes (UMLS CUI), what literature-curated biomarkers does BiomarkerKG record (MONDO), bridged through ubergraph UMLS->MONDO?
Which BiomarkerKG diseases with curated biomarkers (MONDO) also appear in biohealth with SDoH context, bridged MONDO->UMLS? |
| biohealth → ubergraph → nde | UMLS↔MONDO | 2,760 | For a disease biohealth describes (UMLS CUI), what NIAID infectious/immune-disease datasets exist (nde, MONDO), bridged through ubergraph UMLS->MONDO?
For an NIAID dataset disease in NDE (MONDO), what SDoH and clinical associations does biohealth attach, bridged MONDO->UMLS? |
| biohealth → ubergraph → oard-kg | UMLS↔MONDO | 1,796 | For a disease biohealth describes (UMLS CUI, with SDoH + clinical context), what real-world EHR phenotype co-occurrences does OARD record (MONDO), bridged through ubergraph UMLS->MONDO?
For type 2 diabetes present in both graphs, contrast biohealth's SDoH determinants against OARD's EHR-derived phenotype co-occurrences for the same MONDO disease. |
| biohealth → ubergraph → rdkg | UMLS↔MONDO | 9,122 | For a disease biohealth describes (UMLS CUI, with its SDoH and clinical associations), what rare-disease gene/drug associations does rdkg record (MONDO), bridged through ubergraph UMLS->MONDO?
For a rare disease RDKG has drug associations for (MONDO), what SDoH and clinical associations does biohealth attach via its UMLS CUI, bridged MONDO->UMLS? |
| biohealth → ubergraph → spoke-okn | UMLS↔MONDO↔DOID | 173 | For a disease biohealth describes (UMLS CUI), pull its spoke-okn gene / compound / prevalence associations (DOID), bridged through ubergraph UMLS->MONDO->DOID.
For a spoke-okn disease with prevalence/mortality data (DOID), what social-determinant associations does biohealth carry, bridged DOID->MONDO->UMLS? |
Social Determinants & Services
Starting from a condition biohealth links in its literature graph (e.g. obesity), which County Health Rankings SDoH indicators does spoke-okn track geographically for it, reached backward through the UMLS->MeSH wikidata bridge?
Of the 89 SDoH concepts whose SNOMED label matches a biohealth UMLS concept name, how many carry disease associations in biohealth's literature graph, and which behavioural determinant links to the most conditions?
For the 8 PHASES psychosocial constructs that resolve to a biohealth UMLS concept, which single construct (e.g. social isolation) surfaces the largest set of linked conditions and determinants in the literature graph?
Given a condition biohealth documents in its clinical/SDoH graph (e.g. diabetes), which DREAM-KG social services list that condition as their audienceType, matched on the concept label?